Successful treatment of an aciclovir-resistant herpes simplex type 2 infection with cidofovir in an AIDS patient

British Journal of Dermatology

Volumn 147, Issue 1, 2002, Pages 134-138

  Kopp, Tamara ^a   Geusau, A ^a   Rieger, A ^a   Stingl, G ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Aciclovir resistant; Cidofovir; Herpes simplex virus; Human immunodeficiency virus; Treatment

Indexed keywords

ABACAVIR; ACICLOVIR; CIDOFOVIR; DIDANOSINE; GANCICLOVIR; LAMIVUDINE; NEVIRAPINE; PROBENECID; RITONAVIR; VALACICLOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ANUS DISEASE; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL SYMPTOM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; NAUSEA; NEPHROTOXICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN ULCER; TREATMENT OUTCOME; VIRUS ISOLATION; VIRUS PNEUMONIA; VOMITING;

ACYCLOVIR; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOSINE; DRUG RESISTANCE, VIRAL; FEMALE; FISSURE IN ANO; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS;

EID: 0036068109     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04747.x     Document Type: Article

References (23)

1. High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London
2. Relation between herpes simplex viruses and human immunodeficiency virus infections
3. Acyclovir: An effective antiviral
4. A double-blind randomized study assessing the equivalence of valacyclovir 1000 mg once daily versus 500 mg twice daily in the episodic treatment of recurrent genital herpes
5. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind placebo-controlled trial
6. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome
7. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir
8. Characterization of acyclovir-resistant and-sensitive herpes simplex virus from a patient with an acquired immune deficiency
9. Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases
10. Therapeutic potential of cidofovir (HPMPC Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections
11. Acyclovir-resistant herpes in AIDS treated with foscarnet
12. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome
13. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS
14. A randomized double-blind placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS
15. Cidofovir
16. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis
17. Herpesvirus resistance to antiviral drugs: A review of the mechanisms: Clinical importance and therapeutic options
18. (S)-1-(3-hydroxy-2-phosphonyl-meth-oxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis
19. Biochemical basis for increased susceptibility to cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity
20. 1-[((S)-2-hydroxy2-oxo-142-dioxaphosphorinan-5-yl)methyl] cytosine an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo
21. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)
22. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized controlled trial
23. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis